Salk Cancer Center

Press & News

Salk Institute for Biological Studies - Salk Cancer Center - Press & News

News


Salk scientists reveal most commonly mutated gene in all cancers

LA JOLLA—For the past fifteen years, cancer researchers have been using DNA sequencing technology to identify the gene mutations that cause different forms of cancer. Now, Salk Assistant Professor Edward …


Peter Adams and Gerald Shadel awarded $13 million from NIH to study aging and liver cancer

LA JOLLA—Sanford Burnham Prebys Professor Peter D. Adams, who directs the Aging, Cancer and Immuno-oncology Program, and Salk Institute Professor Gerald Shadel, who directs the San Diego Nathan Shock Center …


The Salk Institute and Sanford Burnham Prebys license ULK1/2 inhibitors to Endeavor BioMedicines for treatment of cancer

LA JOLLA—The Salk Institute, along with Sanford Burnham Prebys, have signed an exclusive licensing agreement with California-based Endeavor BioMedicines for an intellectual property portfolio relating to cancer therapeutics and diagnostics …


Salk promotes Diana Hargreaves to associate professor

LA JOLLA—The Salk Institute has promoted Diana Hargreaves to the rank of associate professor for her notable contributions in epigenetic regulation, which make specific regions of our DNA accessible to …


“Bad fat” suppresses killer T cells from attacking cancer

LA JOLLA—In order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized “killer” T cells. Salk researchers led by Professor Susan Kaech …


Salk scientists reveal role of genetic switch in pigmentation and melanoma

LA JOLLA—Despite only accounting for about 1 percent of skin cancers, melanoma causes the majority of skin cancer-related deaths. While treatments for this serious disease do exist, these drugs can …


Dannielle Engle awarded prestigious pancreatic cancer research grant honoring Ruth Bader Ginsburg

LA JOLLA—Salk Assistant Professor Dannielle Engle was selected as the first recipient of the Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research in Honor of Ruth Bader Ginsburg, the …


Parkinson’s, cancer, type 2 diabetes share a key element that drives disease

LA JOLLA—When cells are stressed, chemical alarms go off, setting in motion a flurry of activity that protects the cell’s most important players. During the rush, a protein called Parkin …


Salk Scientists receive $1.5 million from The Conrad Prebys Foundation’s inaugural grant cycle

LA JOLLA—Salk Professor Thomas Albright has been awarded $1 million and Assistant Professor Edward Stites awarded $500,000 by The Conrad Prebys Foundation as part of its inaugural round of grants. …


Salk receives $1 million from BioMed Realty to support innovative cancer research and faculty

LA JOLLA—The Salk Institute received a matching $1 million gift from the BioMed Realty Management Team, which was used to fund the recruitment of award-winning cancer researcher Christina Towers and …


Salk team reveals never-before-seen antibody binding, informing both liver cancer and antibody design

LA JOLLA—In structural biology, some molecules are so unusual they can only be captured with a unique set of tools. That’s precisely how a multi-institutional research team led by Salk …


Award-winning cancer researcher to join Salk faculty

LA JOLLA—The Salk Institute is excited to welcome Assistant Professor Christina Towers, a top researcher in the field of cancer biology. Towers will join Salk’s renowned NCI-designated Cancer Center to …


Salk Assistant Professor Dannielle Engle awarded over $1 million to study impact of tobacco use on pancreatic cancer

LA JOLLA—Salk Institute Assistant Professor Dannielle Engle has been awarded a New Investigator Award from the Tobacco-Related Disease Research Program (TRDRP) to examine how tobacco use promotes cellular changes that …


Salk Institute and BridgeBio Pharma collaborate to advance therapies for genetically driven disease

LA JOLLA and PALO ALTO, Calif.—The Salk Institute and BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced a three-year collaboration agreement formed to advance cutting-edge academic discoveries in genetically driven diseases …


Salk physician-scientist Edward Stites receives NIH Director’s New Innovator Award

LA JOLLA—Salk Institute Assistant Professor Edward Stites has been named an NIH Director’s New Innovator for 2020 as part of the National Institutes of Health’s High-Risk, High-Reward Research Program. The award “supports …


More News